Tirzepatides cardiovascular outcome trials are still ongoing, though early indicators suggest it may offer similar or potentially greater cardiovascular protection given its superior metabolic effects
Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks
Approved by the FDA in 2021 for treating type-2 diabetes, GLP-1s have more recently been used to great effect in combating obesity, a condition that affects some 42% of American adults
The disability data alone tells the story
Everything changed after scheduling a consultation with the medical weight loss team at Florida Surgery & Weight Loss Center
For anyone taking other medications, trying to cram their pills into a busy morning or with an unpredictable eating schedule, injection may be best or orforglipron